Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
Clinical trial NCT01635959 · COMPLETED
Trial details
- NCT number
- NCT01635959
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 3170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.